Global Uveitis Treatment Market (2020 to 2025) – Industry Trends, Share, Size, Growth, Opportunity and Forecast – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Uveitis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The global uveitis treatment market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global uveitis treatment market to continue its moderate growth during the next five years.

Uveitis treatment refers to various therapeutic procedures for treating inflammation in the uvea and surrounding tissues. The disease is characterized by blurred vision, dark or floating spots in the vision, redness of eye and sensitivity to light. Some of the commonly used uveitis treatment methods include topical, systemic and local corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, antibiotics, analgesics and antivirals and antifungal medicines. These therapeutics are directed toward reducing inflammation, alleviating pain, preventing further tissue damage and restoring vision loss and can be used to treat conditions, including anterior uveitis, intermediate uveitis, posterior uveitis and panuveitis.

The increasing prevalence of optical infections and chronic eye disorders across the globe represents one of the key factors driving the growth of the market. Uveitis is highly prevalent among individuals suffering from diabetes, eye injuries, cataract, glaucoma, cystoid macular edema, band keratopathy and autoimmune and inflammatory disorders. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness regarding the available treatment alternatives for managing uveitis has resulted in a significant increase in the demand for corticosteroid treatments among patients and healthcare providers.

Additionally, various technological advancements in the treatment alternatives, such as the development of non-steroidal injectables and anti-tumor necrosis factor (TNF) drugs, are acting as other growth-inducing factors. These biological therapeutic agents are effective in the treatment of chronic uveitis and are administered as subcutaneous injections. Other factors, including the implementation of favorable initiatives by the governments to promote public health, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

(Read more…)

Companies Mentioned

• AbbVie Inc.
• Alimera Sciences Inc.
• Bausch & Lomb Incorporated (Bausch Health)
• Enzo Biochem Inc.
• Eyegate Pharmaceuticals Inc.
• Eyepoint Pharmaceuticals Inc.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd

Key Questions Answered in This Report:

• How has the global uveitis treatment market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global uveitis treatment market?
• What are the key regional markets?
• What is the breakup of the market based on the treatment type?
• What is the breakup of the market based on the disease type?
• What is the breakup of the market based on the cause?
• What is the breakup of the market based on the distribution channel?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global uveitis treatment market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Uveitis Treatment Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Treatment Type

6.1 Corticosteroids

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Immunosuppressant

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Monoclonal Antibodies

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 Cycloplegic Agents

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 Antibiotics

6.5.1 Market Trends

6.5.2 Market Forecast

6.6 Antivirals

6.6.1 Market Trends

6.6.2 Market Forecast

6.7 Antifungal

6.7.1 Market Trends

6.7.2 Market Forecast

6.8 Analgesics

6.8.1 Market Trends

6.8.2 Market Forecast

7 Market Breakup by Disease Type

7.1 Anterior Uveitis

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Posterior Uveitis

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Intermediate Uveitis

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Panuveitis

7.4.1 Market Trends

7.4.2 Market Forecast

8 Market Breakup by Cause

8.1 Infectious

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Non-infectious

8.2.1 Market Trends

8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 Retail Pharmacies

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Online Pharmacies

9.3.1 Market Trends

9.3.2 Market Forecast

9.4 Others

9.4.1 Market Trends

9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America

10.2 Asia Pacific

10.3 Europe

10.4 Latin America

10.5 Middle East and Africa

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/uy8vat

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900